Identification of progressive mild cognitive impairment patients using incomplete longitudinal MRI scans

Kim-Han Thung1, Chong-Yaw Wee1,2, Pew-Thian Yap1

  • 1Department of Radiology and BRIC, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Brain Structure & Function
|November 26, 2015
PubMed

Insights

Distinguishing progressive mild cognitive impairment (pMCI) from stable mild cognitive impairment (sMCI) is crucial for early Alzheimer's disease (AD) detection. Utilizing longitudinal MRI data significantly improves diagnostic accuracy for pMCI/sMCI classification.

Area of Science:

  • Neuroimaging
  • Machine Learning
  • Biostatistics

Background:

  • Accurate differentiation between progressive mild cognitive impairment (pMCI) and stable mild cognitive impairment (sMCI) is essential for timely intervention in potential Alzheimer's disease (AD) patients.
  • Longitudinal data offers valuable insights into disease progression but can be incomplete, posing challenges for analysis.

Purpose of the Study:

  • To develop and evaluate a classification framework for pMCI/sMCI using incomplete longitudinal magnetic resonance imaging (MRI) data.
  • To enhance diagnostic accuracy by integrating dynamic features derived from serial MRI scans.

Main Methods:

  • Extraction of volumetric and dynamic features from longitudinal MRI scans at baseline and 6, 12, and 18 months.
  • Feature selection using elastic net sparse learning algorithms and imputation of missing data via low-rank matrix completion.
  • Classification of pMCI/sMCI using a multi-kernel support vector machine (mkSVM) on the completed feature matrix.

Main Results:

  • The proposed framework achieved a diagnostic accuracy of 78.2% when incorporating longitudinal MRI information.
  • This represents a 6.6% improvement in accuracy compared to using only baseline MRI data.
  • The study demonstrates the value of longitudinal disease history in improving diagnostic precision.

Conclusions:

  • Harnessing incomplete longitudinal MRI data with advanced machine learning techniques can significantly improve the accuracy of distinguishing pMCI from sMCI.
  • The developed framework offers a promising approach for early identification of individuals at risk for Alzheimer's disease.
  • Integrating dynamic features and robust imputation methods is key to leveraging the full potential of longitudinal neuroimaging data.

Related Concept Videos